Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
Learn more about:
Related Access Program
Related Clinical Trial
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer and Cervical Cancer
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
Sentinel Lymph Node Biopsy Versus Lymphadenectomy in Endometrial Cancer
The LYSA (Linking You to Support and Advice) Trial
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
The Role of Endometrial Blood Flow in Endometrial Cancer
Vibrational Spectroscopy for Endometrial Cancer Diagnosis
Adipocytokines in Endometrial Cancer
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
Risk Assessment of Endometrial Hyperplasia and Endometrial Cancer
Sentinel Lymph Node Biopsy Predictive Value in Endometrial Cancer of Low and Intermediate Risk
Comparison of Nodal Staging in Endometrial Cancer
Pelvic Sentinel Node Detection Using Indocyanine Green Learning Curve
Adjuvant Radiotherapy in Patients With Early Endometrial Cancer
Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study)
Advanced or Recurrent Ovarian, Cervical, and Endometrial Cancer Treated With SHetA2
Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
The Compatibility of Preoperative Endometrial Biopsies With Postoperative Final Pathology in Endometrial Cancer
Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II
Stereotactic Pelvic Adjuvant Radiation TherApy in Cancers of the UteruS
Prospective Randomized Comparison of Sentinel Lymph Node Mapping and Conventional Pelvic Lymph Node Dissection in Early Stage Endometrial Cancer
Analysis of miRNA Expression in Endometrial Cancer
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia
4FMFES-PET Imaging of Endometrial and Ovarian Cancers
Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System
Endometrial Cancer International Database
Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
Improving Care After Inherited Cancer Testing
Radiation and TSR-042 in People With Endometrial Cancer After They Receive Surgery
Time Restricted Eating (TRE) Among Endometrial Cancer Patients
Comparison of Toxicities Between Proton Therapy and IMRT for Post Operative Treatment of Endometrial or Cervical Cancers.
Study of Copanlisib and Ketogenic Diet
Onapristone and Anastrozole in Refractory Estrogen and Progesterone Positive Endometrial Cancer
Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer
Implementing Enhanced Recovery After Surgery (ERAS) Pathways In Major Gynecologic Oncology Operations In Greece
Adipocytokines in Endometrial Cancer
Tracers for Endometrial Cancer Sentinel Node Labeling
Cell-free DNA Methylation for Endometrial Cancer
Efficacy of Paxman Scalp Cooling to Prevent Chemo Induced Alopecia in Black Patients With Breast or GYN Cancers
Anti-ALPP CAR-T Cells Immunotherapy for Ovarian and Endometrial Cancer
Pilot Trial of SP-2577 Plus Pembrolizumab in Select Gynecologic Cancers
Relationship of Endometrial Cancer and Serum Soluble L1CAM Level
Study of CYH33, an Oral α-specific PI3K Inhibitor in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
A Prospective Study Comparing Three Injection Sites to Detect Sentinel Lymph Nodes in Endometrial Cancer
Choosing Ovarian Preservation or Removal Before Surgery for Endometrial Cancer
Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Intraoperative Examination of Sentinel Node in Endometrial Cancer (TRSGO-SLN-003)
Tumor Grade Determines PD-1/PDL-1 Expression
The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach
Bone Marrow Sparing Image-Guided Radiation Therapy (RT) Incorporating Novel Use of GCSF and FDG-PET Imaging
To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer
Mindfulness in Endometrial and Cervical Cancer
Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial Cancer
European Collaborative Multicenter Observational Study: Modular Treatment With PMMR and Targeted Compartmental Pelvic Lymphadenectomy Followed by Therapeutic Pelvic and Paraaortic Lymphadenectomy in Node Positive Disease for Locoregional Control in Endometrial Cancer FIGO Stages I-III
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Colorectal, or Gastric Cancer
Sentinel Node in Endometrial Cancer
Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
A Study of Targeted Agents With Atezolizumab for Patients With Recurrent or Persistent Endometrial Cancer
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.
Adjuvant Hypofractionated Whole Pelvis Radiation Therapy in Endometrial Cancer
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer
Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors.
CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers
Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules
Effectiveness of Care in Certified Cancer Centres in Germany
PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors
Survivorship Promotion In Reducing IGF-1 Trial
Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel
Study of PF‑06940434 in Patients With Advanced or Metastatic Solid Tumors.
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health
Gyn Onc Prehab Study
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
Clinical Database and Biobank of Patients With Gynecologic Neoplasms
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
Continuation of Follow-up of DES-Exposed Cohorts
A Study of Patients Receiving High-Dose Rate Brachytherapy
Effects of Centering Pre-operative Counseling on Patient Reported Anxiety
Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer
Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies – (FIGHT-101)
COM701 in Subjects With Advanced Solid Tumors
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors
FPA150 in Patients With Advanced Solid Tumors
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
Carboplatin-cyclophosphamide Combined With Atezolizumab
Probe-based and Needle-based Confocal Laser Endomicroscopy During Gynaecological Procedures.
Study of Vaginal Dilator Use After Pelvic Radiotherapy
Hula, a Physical Activity Intervention for Female-Cancer Survivors
Clinical Characters of the Diagnosis and Treatment of Gynecological Malignant Tumors in China : A Real World Study
Predictive Clinical and Biological Parameters in Gynecological Cancer – GC-BIO-IPC 2013-010
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
Comparison of the Effects of Fentanyl, Oxycodone, Butorphanol on Gastrointestinal Function
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer
Extended Follow-up of Columbia, MO Serum Bank Participants
A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment
A Study of Sacituzumab Govitecan in Metastatic Solid Tumors (TROPICS-03)
Can the iKnife Distinguish Between Normal and Malignant Endometrial Tissue?
Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma
Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)
Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project
Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole
ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers
Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic Factors
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy
Multiorgan Metabolic Imaging Response Assessment of Abemaciclib
The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Determining the Sensitivity of Sentinel Lymph Nodes Identified With Robotic Fluorescence Imaging
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Biomarkers for Gynecologic Cancer
A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
Application of Tachosil During Lymphadenectomy
Evaluation of Indocyanine Green-guided Systematic Pelvic Lymphadenectomy in Endometrial and Cervical Cancer
Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer
A Controlled Study of Quality of Life and it’s Related Factors Among Gynecological Cancer Survivors
A Novel Tapered Applicator for Vaginal Vault Brachytherapy
Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients
Quality of Life in Survivors of Gynecologic Cancer
Endometrial Polyps: Pathophysiology and Clinical Consequences
Radiation Therapy in Uterine Cancer: Dosimetry Analysis, Clinical Implication, and Survival Analysis
A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus
2D vs 3D Planning for High-Dose Rate (HDR) Gynecological Brachytherapy
PET-CT vs. Integrated MR-PET Scanning of GYN Cancers
Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification
Evaluation of the Proliferative Activities of Insulin Analogues in Primary Human Tumor Cells
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma
CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer
Antitumoral Activity and Safety of AEZS-108 in Women With LHRH Receptor Positive Gynecological Tumors
Bone Mineral Density and Subsequent Cancer Risk
Bevacizumab and Rucaparib in Recurrent Carcinoma of the Cervix or Endometrium
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
Non-Hormonal Vaginal Moisturizer in Hormone-Receptor Positive Postmenopausal Cancer Survivors Experiencing Estrogen Deprivation Symptoms on Vulvovaginal Health
OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer
Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen
Cancer of the Uterus and Treatment of Stress Urinary Incontinence
Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
Multi-omics Study on the Pathogenesis of Malignant Transformation of Adenomyosis
Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
Assessment of Screening Modalities for Gynecologic Cancers
Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer
Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
Biomarker Guided Treatment in Gynaecological Cancer
Positron Emission Tomography (PET) Imaging Studies With NIS Reporter
Tachosil for the Prevention of Symptomatic Lymph Cysts
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors
Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer
Multimedia Aid Gynecologic Counseling and Consent
Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC
Pembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study
Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?
Translating Healthy Lifestyle Interventions for Cancer Survivors
Screening for Endometrial Abnormalities in Overweight and Obese Women
A Trial for Patients With Advanced/Recurrent Endometrial Cancer
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Patients With Endometrioid Cancer
Intra-Operative Lymphatic Mapping in Patients With Invasive Carcinoma of the Cervix or Endometrial Carcinoma
Pembro/Carbo/Taxol in Endometrial Cancer
Evaluation of Fluciclovine Uptake in Patients With Cervical, Ovarian Epithelial or Endometrial Cancers.
Robot-assisted Laparoscopic Hysterectomy-RALH- Postoperative Complications, Quality of Life and Health Economics
Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium
Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
Vaginal Cuff Brachytherapy Fractionation Study
MK-3475 Immunotherapy in Endometrial Carcinoma
Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer
Anxiety and Distress Levels in Women With Suspected Endometrial Cancer
Advanced Methods for Cancer Detection by Vaginal Screening
END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer
Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.
Mirvetuximab Soravtansine (IMGN853) and Bevacizumab in Patients With Endometrial Cancer
Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients
Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Quality of Life After Robotic Surgery for Endometrial Cancer
SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Pembrolizumab With Axitinib in Recurrent Endometrial Cancer
A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer
Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
Prognostic Impact of Programmed Death Ligand-1 Expression in Advanced Endometrial Cancer
Zoptarelin Doxorubicin (AEZS 108) as Second Line Therapy for Endometrial Cancer
Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer
Laparoscopic Approach to Cancer of the Endometrium
Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer
Maintenance With Selinexor/Placebo After Combination Chemotherapy in Endometrial Cancer [SIENDO]
BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer
A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Screening of Biomarkers on Endometrial Cancers
Papillary Serous Carcinoma of the Endometrium
Sentinel Node Biopsy in Endometrial Cancer
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
A Study to Assess the Efficacy and Safety of ABTL0812
Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma/Intraepithelial Neoplasia
Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer
Value of Diffusion Weighted Magnetic Resonance Imaging in Detection of Recurrent Disease in Surgically Treated Cervical and Endometrial Cancer Patients
Exercise and Healthy Diet or Standard Care in Patients in Remission From Stage I or Stage II Endometrial Cancer
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)
DOvEEgene: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics
Effect of a Lifestyle Intervention on Nutritional Status and Prognosis of Endometrial Cancer Survivors
Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02)
Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy
Exercise as an Intervention in Endometrial Cancer Survivors
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model
Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery
Protein-Sparing Modified Fast Intervention for Weight Loss in Obese Endometrial Cancer Survivors
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer
Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
Effect of Fertility-sparing Therapy of Early Endometrial Cancer
Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer
Indocyanine Green and Near-infrared Fluorescence Imaging to Detect Sentinel Lymph Nodes in Patients With Endometrial Cancer
A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Pembrolizumab in Ultramutated and Hypermutated Endometrial Cancer
Endometrial Cancer Conservative Treatment (E.C.Co). A Multicentre Archive
Combination Chemotherapy With Nintedanib / Placebo in Endometrial Cancer
Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer
Different Risk Stratification Models for Prediction of Lymph Node Involvement in Endometrial Carcinoma
ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Lymphedema in Endometrial Cancer
Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma
Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Fertility Sparing Management of EndomeTrial Cancer and Hyperplasia
High Intensity Interval Training in Endometrial Cancer
A Pilot Study to Determine the Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer
Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer
Single Agent ONC201 in Recurrent or Metastatic Endometrial Cancer
3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer
A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
Sentinel Node Detection in Endometrial Cancer: A Consolidation Study on Detection Rates of Metastatic Disease
Biomarkers for Diagnosis and Prognosis of Endometrial Carcinoma
Retrospective Case Study Examining Patient Outcomes Compared to the ChemoFx Assay in Endometrial Cancer Patients
Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer
Disseminated Endometrial Cancer Cells During Sonohysterography
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
ENdometrial Cancer SURvivors’ Follow-up carE (ENSURE): Less is More?
Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients
Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer
Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer
Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer
Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial Cancer
Study of Niraparib and TSR-042 in Recurrent Endometrial Cancer
Endometrial Cancer – LOHP Alone and With 5FU
Exemestane in Advanced and Recurrent Endometrial Carcinoma
Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium
the Effectiveness of a Weight Management Program in Patients Who Have Completed Treatment for Endometrial Cancer
Preoperative Window Study of Metformin for the Treatment of Endometrial Cancer
SLNM in Endometrial Cancer Combined With OSNA
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment
Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer
Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
Neoadjuvant Celecoxib in Newly Diagnosed Patients With Endometrial Carcinoma
Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients
Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer
Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer
Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial Cancer
Role of Uterine Manipulator in Hysterectomy – Ro.Man.HY
TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors
Mirena® ± Metformin as Fertility-preserving Treatment for Young Asian Women With Early Endometrial Cancer
Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission
Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer
Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer
External-Beam Radiation Therapy Compared With Vaginal Brachytherapy After Surgery for Stage I Endometrial Cancer
Cost-utility of Ambulatory Surgery in the Management of Endometrial Cancer(AMBU-ENDO)
Doxorubicin and Cisplatin With or Without Paclitaxel in Treating Patients With Locally Advanced, Metastatic, and/or Relapsed Endometrial Cancer
Endometrial Cancer and Robotic-assisted Versus Traditional Laparoscopy
Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer
Epidemiological Analysis on Endometrial Cancer in Guangdong Province of China
Window of Opportunity Study of Pembrolizumab in Early Stage, High Grade Obesity-driven Endometrial Cancer
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer
Prospective, Observational Study of Low-risk Criteria for Node Metastasis in Endometrial Cancer
A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients
VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.
Abemaciclib With Letrozole in Recurrent or Persistent Endometrial Cancer
Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
Everolimus in Treating Patients With Relapsed or Metastatic Endometrial Cancer
Feasibility Study of Laparoendoscopic Single Site Surgical Staging for Endometrial Cancer
Photoacoustic Endoscopy in Endometrial Cancer
RAD001 in Recurrent Endometrial Cancer Patients
Psychosocial Benefits of Exercise in Endometrial Cancer Survivors
Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer
Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer
A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)
Scale Down for Endometrial Cancer
Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer
Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer
Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer
Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Patient’s Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding
Factors Affecting the Prognosis of Patients With Endometrial Cancer
Anti-PD-1 Antibody Combined With Anlotinib in the Treatment of Endometrial Cancer
GINECO-EN102b – BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer
Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer
2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial
Risk Factors for Endometrial Cancer in Black Women
Retrospective Study to Evaluate the Feasibility of Ovarian Preservation in Patients With Endometrial Carcinoma
Sexual Functioning in Endometrial Cancer
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
A Randomized, Controlled, Comparative Study of a Levonorgestrel Intrauterine System for the Prevention of Endometrial Cancer in Patients Aged 40-50 With BMI Greater Than 35
Molecular Staging of Endometrial Cancer
Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer
Evaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
Sentinel Node Mapping in High Risk Endometrial Cancer
The Effects of the Endocrine System on Endometrial Cancer
Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer
Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation
Can 3D Ultrasound be Used as an Alternative to MRI to Assess Myometrial Invasion in Endometrial Cancer?
Hysteroscopic Lymphatic Mapping for Endometrial Cancer
Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer
Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer
CT Assessment of BMI in Endometrial Cancer Patients
MOtiVating Endometrial Cancer Survivors With Activity Monitors and Tailored Feedback
Study of the Weekly Oral RAD001 in Combination With Oral Topotecan in Patients With Advanced or Recurrent Endometrial Cancers
The Role of Functional MRI and Doppler Sonography in Assessing Blood Vessel Formation Within the Tumors of Endometrial Cancer Patients
A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC)
Pilot Study Using a PET Gamma Probe to Evaluate Lymph Nodes in Endometrial Cancer
AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)
Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG
Lymph Node Mapping in Patients With Endometrial Cancer
Adjuvant Stereotactic Pelvic Irradiation in Endometrial Cancer
Estrogen, Diet, Genetics and Endometrial Cancer
Effect of Uterine Manipulator on Recurrence and Mortality of Endometrial Cancer
Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer
Study of Genes and the Environment in Patients With Endometrial Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
Racial Disparity in Endometrial Cancer
Follow-up of Endometrial Cancer Patients
Can Staging Magnetic Resonance Imaging (MRI) Features Prognosticate Patients Presenting With Endometrial Cancer?
Endometrial Cancer Diet and Exercise
Treatment With Medroxyprogesterone Acetate Plus LNG-IUS in Young Women With Early Stage Endometrial Cancer
BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers
Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients
Human Epididymis Protein 4 in Endometrial Carcinoma
The Multicentic Trial in Fertility-sparing Treatment and Ovarian Preservation Management for Early Endometrial Cancer
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy
The DETECT Study: Discovery and Evaluation of Testing for Endometrial Cancer in Tampons
Study of Insulin Resistance and Endometrial Cancer in Harris County, Texas
Physical Activity After Endometrial Cancer
Research of Circulating Tumor Cells Released During Endometrial Cancer Surgery.
The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer
Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
Dendritic Cells for Immunotherapy of Metastatic Endometrial Cancer Patients
Urinary miRNA in Endometrial Cancer Study
Ketohexokinase Isoforms in Endometrial Cancer.
PET/CT in the Management of Patients With Early Stage Endometrial Cancer
Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer
Telephone Follow-up After Treatment for Endometrial Cancer
Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression
Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial Cancer
Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
HE4 is a Beneficial Biomarker in Endometrial Cancer